Financial Statement MD&A Financial Statement Revise 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed Consolidated Q1 31/03/2022 2022 Reviewed
PUBLIC CO.,LTD. 2021 18/03/2022 Finanacial Statements ( 22 record(s) found) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2024 Reviewed Consolidated Q3 30/09/2024
Finanacial Statements ( 4 record(s) found) Name Year Status Type Period As Of Details Nakornthon Hospital Public Company Limited 2024 Reviewed Consolidated Q3 30/09/2024 Nakornthon Hospital Public Company
2024 Reviewed Company Q3 30/09/2024 2024 Reviewed Consolidated Q3 30/09/2024 2024 Reviewed Consolidated Q2 30/06/2024 2024 Reviewed Company Q2 30/06/2024 2024 Reviewed Q1 31/03
Cannabiz way Co., Ltd and CBD Bioscience Co., Ltd that would impact on the consolidated financial statements and the separate financial statements. Therefore, the SEC has notified EE (1) to review and
attended by over 80 regulators and audit firm representatives from 6 ASEAN countries and Hong Kong. Besides the AARG members comprising Malaysia?s AOB, Singapore?s Accounting and Corporate Regulatory
PUBLIC COMPANY LIMITED 2001 Reviewed Consolidated Q3 30/09/2001 KUANG PEI SAN FOOD PRODUCTS PUBLIC COMPANY LIMITED 2001 Reviewed Company Q2 30/06/2001 KUANG PEI SAN FOOD PRODUCTS PUBLIC COMPANY LIMITED
the outbreak of COVID-19. However, when combined with the interim dividend payment for the first half of the year 2019 (January - June 2019) at the rate of Baht 0.50 per share, the total dividend
of consideration basis, calculated from the Company’s reviewed consolidated financial statements for 6-month period as of 30 June 2018. Therefore, the entering of transaction when combined with the